Predictors of lipoprotein particle size and subclasses in patients with OSA

R. Tisko, Z. Jelic-Ivanovic, V. Habalova, Z. Sopkova, E. Slaba, J. Vekic, Z. Dorkova, A. Zeljkovic, P. Joppa, M. Rizzo, R. Tkacova (Kosice, Slovakia; Palermo, Italy; Belgrade, Republic Of Serbia)

Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing
Session: Of mice and men: sleep disordered breathing
Session type: Oral Presentation
Number: 3051
Disease area: Sleep and breathing disorders

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Tisko, Z. Jelic-Ivanovic, V. Habalova, Z. Sopkova, E. Slaba, J. Vekic, Z. Dorkova, A. Zeljkovic, P. Joppa, M. Rizzo, R. Tkacova (Kosice, Slovakia; Palermo, Italy; Belgrade, Republic Of Serbia). Predictors of lipoprotein particle size and subclasses in patients with OSA. Eur Respir J 2013; 42: Suppl. 57, 3051

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Genetic predisposition to arterial hypertension in patients with OSA
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013

Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA)
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015


Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels
Source: Eur Respir J 2006; 27: 121-127
Year: 2006



Evaluation of lipid profile in patients with obstructive sleep apnea syndrome
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015


Type 2 diabetes and the risk for obstructive sleep apnoea in Nigeria
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015

Interaction between body weight obstructive sleep apnea (OSA) on C-reactive protein (CRP) in an otherwise healthy population: The EPIOSA study
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015


Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in male and female patients with OSAS
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014

Serum midkine levels in patients with obstructive sleep apnea
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015


Lipid peroxidation and protein oxidation are related to the severity of OSAS
Source: International Congress 2014 – Sleep disordered breathing 5
Year: 2014


Effects of CPAP on albumin redox state and heart rate variability in OSA patients
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013


Prevalence of metabolic syndrome (MS) in a population of apneic patients:A prospective study with cardiovascular risk estimation
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014


Liver enzymes in OSA patients at diagnosis: The Mallorca cohort
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014


Prevalence and predictive factors of sleep breathing disorders (SBD) in severe COPD patients
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014


High prevalence of sleep disordered breathing (SDB) in patients with systemic AL amyloidosis
Source: International Congress 2014 – Sleep disordered breathing: from children to the elderly
Year: 2014


Effects of OSA on metabolic dysfunction in adolescents - is OSA relevant for adolescent obesity?
Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options
Year: 2009


Is IGF-1 a marker of cardio-metabolic risk in sleep apnea syndrome (SAS)?
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016


LATE-BREAKING ABSTRACT: High density lipoprotein cholesterol (HDL) and severe chronic lung disease (CLD) exacerbations in the general population
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015

Application of cluster analysis in OSA population
Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea
Year: 2016

Serum leukotriene B4 levels, tonsillar hypertrophy and obstructive sleep-disordered breathing in childhood
Source: International Congress 2015 – Monitoring sleep-disordered breathing in children and adults
Year: 2015

The rs1800629 variant in the TNF-α gene is not associated with obstructive sleep apnoea syndrome in a Czech population
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015